6,527 reports of this reaction
2.6% of all LAMOTRIGINE reports
#3 most reported adverse reaction
SEIZURE is the #3 most commonly reported adverse reaction for LAMOTRIGINE, manufactured by GlaxoSmithKline LLC. There are 6,527 FDA adverse event reports linking LAMOTRIGINE to SEIZURE. This represents approximately 2.6% of all 249,683 adverse event reports for this drug.
Patients taking LAMOTRIGINE who experience seizure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SEIZURE is a less commonly reported adverse event for LAMOTRIGINE, but still significant enough to appear in the safety profile.
In addition to seizure, the following adverse reactions have been reported for LAMOTRIGINE:
The following drugs have also been linked to seizure in FDA adverse event reports:
SEIZURE has been reported as an adverse event in 6,527 FDA reports for LAMOTRIGINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SEIZURE accounts for approximately 2.6% of all adverse event reports for LAMOTRIGINE, making it one of the most commonly reported side effect.
If you experience seizure while taking LAMOTRIGINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.